A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(84 sites)

United States

University of Southern California, Los Angeles, California

University of California Irvine, Orange, California

University of California San Francisco (UCSF), San Francisco, California

SFM Clinical Research, Boca Raton, Florida

Allied Biomedical Research Institute (ABRI), Miami, Florida